日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cetuximab co-treatment with KRAS G12C inhibitors fulzerasib and sotorasib in human KRAS G12C non-small cell lung cancer cells

西妥昔单抗联合KRAS G12C抑制剂富泽拉西布和索托拉西布治疗人KRAS G12C非小细胞肺癌细胞

Olmo-González, Daniel; Zhou, Mengxin; Oliveira, Nuno G; Zhou, Fusheng; Yan, Feng; González, Jèssica; València-Clua, Kevin; Molina-Vila, Miguel Angel; Bertrán-Alamillo, Jordi; Giménez-Capitán, Ana; Codony-Servat, Jordi; Rosell, Rafael

Repurposing risperidone as an anti-angiogenic agent for triple-negative breast cancer: a computational to in ovo investigation

将利培酮重新用于治疗三阴性乳腺癌的抗血管生成药物:一项从计算机模拟到卵内实验的研究

Jain, Anisha; Motatis, Anil Kumar Belagal; Dharmashekar, Chandan; Shreevatsa, Bhargav; Vs, Siddesh; Srinivas, Monisha; Srinivasa, Sudhanva Muddenahalli; P, Ashwini; Prasad, M N Nagendra; Rosell, Rafael; Codony-Servat, Jordi; Rangappa, Shobith; Iqbal, Muzaffar; Abass, Kasim Sakran; Amachawadi, Raghavendra G; Stupin, Victor; Kollur, Shiva Prasad; Shivamallu, Chandan; Silina, Ekaterina

KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination

基于替泊替尼和奥美拉唑联合治疗的 KRAS 突变非小细胞肺癌 (NSCLC) 疗法

Rafael Rosell, Eloisa Jantus-Lewintre, Peng Cao, Xueting Cai, Baojuan Xing, Masaoki Ito, Jose Luis Gomez-Vazquez, Mireia Marco-Jordán, Silvia Calabuig-Fariñas, Andrés Felipe Cardona, Jordi Codony-Servat, Jessica Gonzalez, Kevin València-Clua, Andrés Aguilar, Carlos Pedraz-Valdunciel, Zahra Dantes, A

Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways

针对合成表皮生长因子变体的疫苗抗体增强了针对 MAPK/ERK 和 PI3K/Akt 通路的抑制剂的抗肿瘤作用

Silvia García-Roman, Mónica Garzón-Ibáñez, Jordi Bertrán-Alamillo, Núria Jordana-Ariza, Ana Giménez-Capitán, Beatriz García-Peláez, Marta Vives-Usano, Jordi Codony-Servat, Erik d'Hondt, Rafael Rosell, Miguel Ángel Molina-Vila

HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer

HMGB1 表达水平与非小细胞肺癌免疫治疗反应相关

Maria González-Cao, Xueting Cai, Jilian Wilhelmina Paulina Bracht, Xuan Han, Yang Yang, Carlos Pedraz-Valdunciel, Teresa Morán, Javier García-Corbacho, Andrés Aguilar, Reyes Bernabé, Pedro De Marchi, Luciane Sussuchi da Silva, Leticia Ferro Leal, Rui Manuel Reis, Jordi Codony-Servat, Eloisa Jantus-L

Biological insights in non-small cell lung cancer

非小细胞肺癌的生物学见解

Rosell, Rafael; Jain, Anisha; Codony-Servat, Jordi; Jantus-Lewintre, Eloisa; Morrison, Blake; Ginesta, Jordi Barretina; González-Cao, María

Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

作者更正:BIM 和 mTOR 表达水平可预测 EGFR 突变型非小细胞肺癌患者对厄洛替尼的疗效

Karachaliou, Niki; Codony-Servat, Jordi; Teixidó, Cristina; Pilotto, Sara; Drozdowskyj, Ana; Codony-Servat, Carles; Giménez-Capitán, Ana; Molina-Vila, Miguel Angel; Bertrán-Alamillo, Jordi; Gervais, Radj; Massuti, Bartomeu; Morán, Teresa; Majem, Margarita; Felip, Enriqueta; Carcereny, Enric; García-Campelo, Rosario; Viteri, Santiago; González-Cao, María; Morales-Espinosa, Daniela; Verlicchi, Alberto; Crisetti, Elisabetta; Chaib, Imane; Santarpia, Mariacarmela; Luis Ramírez, José; Bosch-Barrera, Joaquim; Felipe Cardona, Andrés; de Marinis, Filippo; López-Vivanco, Guillermo; Miguel Sánchez, José; Vergnenegre, Alain; Sánchez Hernández, José Javier; Sperduti, Isabella; Bria, Emilio; Rosell, Rafael

Anti-EGF nanobodies enhance the antitumoral effect of osimertinib and overcome resistance in non-small cell lung cancer (NSCLC) cellular models

抗 EGF 纳米抗体增强奥希替尼的抗肿瘤作用并克服非小细胞肺癌 (NSCLC) 细胞模型中的耐药性

Salvador Guardiola, Macarena Sánchez-Navarro, Rafael Rosell, Ernest Giralt, Jordi Codony-Servat

Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunities

EGFR突变肺癌患者通路共调控:治疗契机

Rosell, Rafael; Cardona, Andrés Felipe; Arrieta, Oscar; Aguilar, Andrés; Ito, Masaoki; Pedraz, Carlos; Codony-Servat, Jordi; Santarpia, Mariacarmela

Anti-epidermal growth factor vaccine antibodies increase the antitumor activity of kinase inhibitors in ALK and RET rearranged lung cancer cells

抗表皮生长因子疫苗抗体增强激酶抑制剂在 ALK 和 RET 重排肺癌细胞中的抗肿瘤活性

Jordi Codony-Servat, Silvia García-Roman, Miguel Ángel Molina-Vila, Jordi Bertran-Alamillo, Santiago Viteri, Erik d'Hondt, Rafael Rosell